Literature DB >> 31479597

Reliable Protocols for Flow Cytometry Analysis of Intracellular Proteins in Pluripotent Stem Cell Derivatives: A Fit-For-Purpose Approach.

Linda Berg Luecke1, Matthew Waas1, Rebekah L Gundry1,2.   

Abstract

Human pluripotent stem cell (hPSC) derivatives are valuable for a variety of research applications and have the potential to revolutionize approaches to personalized medicine. However, differentiation efficiency varies among cell lines and protocols. Therefore, methods to reliably determine cell type identity in cultures of hPSC derivatives in a manner that is consistent among laboratories are needed. While flow cytometry is apt for routine assessment of population heterogeneity, standardized protocols are not available for most cell types. This article describes a workflow for establishing a fit-for-purpose protocol for flow cytometric analysis of hPSC derivatives. Based on the application of this workflow, a standard operating procedure (SOP) was developed for the analysis of cardiac troponin in hPSC-derived cardiomyocytes (hPSC-CM). Throughout the article, important concepts related to antibody validation and gating strategies are presented to enable users to properly validate any antibody of interest and develop a rigorous SOP for their experimental needs.
© 2019 by John Wiley & Sons, Inc. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  flow cytometry; hPSC-CM; heterogeneity; intracellular proteins; quality control

Mesh:

Year:  2019        PMID: 31479597      PMCID: PMC6727984          DOI: 10.1002/cpsc.94

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  5 in total

1.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

Authors:  Alessandra Moretti; Milena Bellin; Andrea Welling; Christian Billy Jung; Jason T Lam; Lorenz Bott-Flügel; Tatjana Dorn; Alexander Goedel; Christian Höhnke; Franz Hofmann; Melchior Seyfarth; Daniel Sinnecker; Albert Schömig; Karl-Ludwig Laugwitz
Journal:  N Engl J Med       Date:  2010-07-21       Impact factor: 91.245

2.  Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.

Authors:  Xonia Carvajal-Vergara; Ana Sevilla; Sunita L D'Souza; Yen-Sin Ang; Christoph Schaniel; Dung-Fang Lee; Lei Yang; Aaron D Kaplan; Eric D Adler; Roye Rozov; Yongchao Ge; Ninette Cohen; Lisa J Edelmann; Betty Chang; Avinash Waghray; Jie Su; Sherly Pardo; Klaske D Lichtenbelt; Marco Tartaglia; Bruce D Gelb; Ihor R Lemischka
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

3.  Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes.

Authors:  Stefan R Braam; Leon Tertoolen; Anja van de Stolpe; Thomas Meyer; Robert Passier; Christine L Mummery
Journal:  Stem Cell Res       Date:  2009-12-03       Impact factor: 2.020

4.  Distinct iPS Cells Show Different Cardiac Differentiation Efficiency.

Authors:  Yohei Ohno; Shinsuke Yuasa; Toru Egashira; Tomohisa Seki; Hisayuki Hashimoto; Shugo Tohyama; Yuki Saito; Akira Kunitomi; Kenichiro Shimoji; Takeshi Onizuka; Toshimi Kageyama; Kojiro Yae; Tomofumi Tanaka; Ruri Kaneda; Fumiyuki Hattori; Mitsushige Murata; Kensuke Kimura; Keiichi Fukuda
Journal:  Stem Cells Int       Date:  2013-10-27       Impact factor: 5.443

5.  Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry.

Authors:  Matthew Waas; Ranjuna Weerasekera; Erin M Kropp; Marisol Romero-Tejeda; Ellen N Poon; Kenneth R Boheler; Paul W Burridge; Rebekah L Gundry
Journal:  Stem Cell Reports       Date:  2019-01-24       Impact factor: 7.765

  5 in total
  2 in total

1.  A call to adopt a "fit for purpose" approach to antibody validation for flow cytometry analyses of stem cell models and beyond.

Authors:  Matthew Waas; Rebekah L Gundry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-27       Impact factor: 4.733

Review 2.  Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications.

Authors:  Maia I Kelly; Mustafa Albahrani; Chase Castro; Ellen Poon; Bin Yan; Jack Littrell; Matthew Waas; Kenneth R Boheler; Rebekah L Gundry
Journal:  Pflugers Arch       Date:  2021-04-08       Impact factor: 3.657

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.